New endoscopic surgery technique for thyroid tumors
Dual-port Trans-subclavian Thyroid Endoscopic Surgery - an Exploration of Cavity Construction in Situ Heralds a New Approach Choice
NA · First Affiliated Hospital of Wenzhou Medical University · NCT06398795
This study is testing a new way to perform thyroid surgery using a small dual-port technique to see if it is safer and more effective than the traditional open surgery for people with thyroid tumors.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | First Affiliated Hospital of Wenzhou Medical University (other) |
| Locations | 1 site (Wenzhou, Zhejiang) |
| Trial ID | NCT06398795 on ClinicalTrials.gov |
What this trial studies
This prospective, single-center study evaluates a novel dual-port trans-subclavian approach to endoscopic thyroid surgery compared to traditional open thyroidectomy. It involves 300 patients with thyroid tumors, divided into an experimental group receiving the new technique and a control group undergoing conventional surgery. The study aims to assess the effectiveness and safety of the new method by comparing surgical complications and collecting laboratory data at specified follow-up points. Adverse events will also be meticulously recorded to provide comprehensive evidence-based insights.
Who should consider this trial
Good fit: Ideal candidates include patients with thyroid cancer or benign thyroid tumors who desire cosmetic improvement from their incisions.
Not a fit: Patients with larger thyroid cancers or benign tumors, severe underlying diseases, or specific autoimmune conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to reduced surgical complications and improved cosmetic outcomes for patients undergoing thyroid surgery.
How similar studies have performed: While endoscopic thyroid surgery has been explored, this specific dual-port approach is relatively novel and has not been widely tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Thyroid cancer or benign thyroid tumors * Patients with a demand for incisional cosmetic improvement Exclusion Criteria: * Patients with thyroid cancer larger than 2 cm * benign tumors larger than 5 cm * Patients with severe underlying diseases * Patients with chronic kidney disease, * Patients with autoimmune diseases * Patients with rheumatoid arthritis
Where this trial is running
Wenzhou, Zhejiang
- First Affiliated Hospital of Wenzhou Medical University — Wenzhou, Zhejiang, China (RECRUITING)
Study contacts
- Principal investigator: Jiashu Wu, Profe — The first hospital of Wenzhou Medical University
- Study coordinator: Chun Jin, Professor
- Email: 845095442@qq.com
- Phone: 86-13858707259
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Thyroid Neoplasms, Endoscopic Surgery